We serve Chemical Name:2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]acetic acid CAS:302901-39-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]acetic acid
CAS.NO:302901-39-9
Synonyms:hms1445p22
Molecular Formula:C12H14O3
Molecular Weight:206.23800
HS Code:2918990090
Physical and Chemical Properties:
Melting point:195-197ºC
Boiling point:384ºC at 760mmHg
Density:1.213g/cm3
Index of Refraction:1.574
PSA:46.53000
Exact Mass:206.09400
LogP:1.94710
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like hms1445p22 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,hms1445p22 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hms1445p22 Use and application,hms1445p22 technical grade,usp/ep/jp grade.
Related News: However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. 2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]acetic acid manufacturer Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]acetic acid supplier Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined. 2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]acetic acid vendor The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. 2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]acetic acid factory The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public.